Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies.

Krisp C, Randall SA, McKay MJ, Molloy MP.

Proteomics Clin Appl. 2012 Jan;6(1-2):42-59. doi: 10.1002/prca.201100062. Epub 2011 Dec 27. Review.

PMID:
22213646
[PubMed - indexed for MEDLINE]
2.

Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis.

Chiu CL, Randall S, Molloy MP.

Bioanalysis. 2009 Jul;1(4):847-55. doi: 10.4155/bio.09.56. Review.

PMID:
21083142
[PubMed - indexed for MEDLINE]
3.

Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.

Lopez MF, Kuppusamy R, Sarracino DA, Prakash A, Athanas M, Krastins B, Rezai T, Sutton JN, Peterman S, Nicolaides K.

J Proteome Res. 2011 Jan 7;10(1):133-42. doi: 10.1021/pr100153j. Epub 2010 Jun 4.

PMID:
20499897
[PubMed - indexed for MEDLINE]
4.

Biomarker validation in blood specimens by selected reaction monitoring mass spectrometry of N-glycosites.

Ossola R, Schiess R, Picotti P, Rinner O, Reiter L, Aebersold R.

Methods Mol Biol. 2011;728:179-94. doi: 10.1007/978-1-61779-068-3_11.

PMID:
21468948
[PubMed - indexed for MEDLINE]
5.

How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease.

Puntmann VO.

Postgrad Med J. 2009 Oct;85(1008):538-45. doi: 10.1136/pgmj.2008.073759. Review.

PMID:
19789193
[PubMed - indexed for MEDLINE]
6.

Application of proteomics in biomarker discovery: a primer for the clinician.

Tambor V, Fucíková A, Lenco J, Kacerovský M, Rehácek V, Stulík J, Pudil R.

Physiol Res. 2010;59(4):471-97. Epub 2009 Nov 20. Review.

PMID:
19929137
[PubMed - indexed for MEDLINE]
Free Article
7.

Multidimensional protein identification technology-selected reaction monitoring improving detection and quantification for protein biomarker studies.

Krisp C, McKay MJ, Wolters DA, Molloy MP.

Anal Chem. 2012 Feb 7;84(3):1592-600. doi: 10.1021/ac2028485. Epub 2012 Jan 24.

PMID:
22224914
[PubMed - indexed for MEDLINE]
8.

Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.

Percy AJ, Byrns S, Chambers AG, Borchers CH.

Expert Rev Proteomics. 2013 Dec;10(6):567-78. doi: 10.1586/14789450.2013.856763. Review.

PMID:
24206229
[PubMed - indexed for MEDLINE]
9.

On the development of plasma protein biomarkers.

Surinova S, Schiess R, Hüttenhain R, Cerciello F, Wollscheid B, Aebersold R.

J Proteome Res. 2011 Jan 7;10(1):5-16. doi: 10.1021/pr1008515. Epub 2010 Dec 13. Review.

PMID:
21142170
[PubMed - indexed for MEDLINE]
10.

Endothelial cell biology and pathology.

Dejana E, Simionescu M, Wolburg H.

Cell Tissue Res. 2009 Jan;335(1):1-3. doi: 10.1007/s00441-008-0697-2. No abstract available.

PMID:
19015887
[PubMed - indexed for MEDLINE]
11.

Computational biology for cardiovascular biomarker discovery.

Azuaje F, Devaux Y, Wagner D.

Brief Bioinform. 2009 Jul;10(4):367-77. doi: 10.1093/bib/bbp008. Epub 2009 Mar 10.

PMID:
19276200
[PubMed - indexed for MEDLINE]
Free Article
12.

Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.

Kolarcik C, Bowser R.

Mol Diagn Ther. 2006;10(5):281-92. Review.

PMID:
17022691
[PubMed - indexed for MEDLINE]
13.

Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay.

Cho CK, Drabovich AP, Batruch I, Diamandis EP.

J Proteomics. 2011 Sep 6;74(10):2052-9. doi: 10.1016/j.jprot.2011.05.025. Epub 2011 May 20.

PMID:
21624510
[PubMed - indexed for MEDLINE]
14.

Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.

Kroksveen AC, Opsahl JA, Aye TT, Ulvik RJ, Berven FS.

J Proteomics. 2011 Apr 1;74(4):371-88. doi: 10.1016/j.jprot.2010.11.010. Epub 2010 Nov 25. Review.

PMID:
21111852
[PubMed - indexed for MEDLINE]
15.

Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?

Fichtlscherer S, Zeiher AM, Dimmeler S.

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2383-90. doi: 10.1161/ATVBAHA.111.226696. Review.

PMID:
22011751
[PubMed - indexed for MEDLINE]
Free Article
16.

Cell cycle checkpoints: the role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases.

Golubnitschaja O.

Amino Acids. 2007;32(3):359-71. Epub 2006 Nov 30. Review.

PMID:
17136506
[PubMed - indexed for MEDLINE]
17.

Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes.

Yassine H, Borges CR, Schaab MR, Billheimer D, Stump C, Reaven P, Lau SS, Nelson R.

Proteomics Clin Appl. 2013 Aug;7(7-8):528-40. doi: 10.1002/prca.201200028. Epub 2013 Jul 9. Review.

PMID:
23696124
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.

Amacher DE.

Toxicol Appl Pharmacol. 2010 May 15;245(1):134-42. doi: 10.1016/j.taap.2010.02.011. Epub 2010 Feb 26. Review.

PMID:
20219512
[PubMed - indexed for MEDLINE]
19.

Strategies for plasma proteomic profiling of cancers.

Omenn GS.

Proteomics. 2006 Oct;6(20):5662-73. Review.

PMID:
16991194
[PubMed - indexed for MEDLINE]
20.

Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Rifai N, Gillette MA, Carr SA.

Nat Biotechnol. 2006 Aug;24(8):971-83. Review.

PMID:
16900146
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk